Safe long-term therapy of Cushing's syndrome over 37 years with mitotane.

MLA

Seibold, Jonas, et al. “Safe Long-Term Therapy of Cushing’s Syndrome over 37 Years with Mitotane.” Frontiers in Endocrinology, vol. 15, Feb. 2024, p. 1294415. EBSCOhost, https://doi.org/10.3389/fendo.2024.1294415.

APA

Seibold, J., Hönemann, M., Tönjes, A., & Sandner, B. (2024). Safe long-term therapy of Cushing’s syndrome over 37 years with mitotane. Frontiers in Endocrinology, 15, 1294415. https://doi.org/10.3389/fendo.2024.1294415

Chicago

Seibold, Jonas, Mario Hönemann, Anke Tönjes, and Benjamin Sandner. 2024. “Safe Long-Term Therapy of Cushing’s Syndrome over 37 Years with Mitotane.” Frontiers in Endocrinology 15 (February): 1294415. doi:10.3389/fendo.2024.1294415.